Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Change in Inventory (2016 - 2018)

Theravance Biopharma (TBPH) has disclosed Change in Inventory for 6 consecutive years, with $1.1 million as the latest value for Q4 2018.

  • On a quarterly basis, Change in Inventory fell 75.17% to $1.1 million in Q4 2018 year-over-year; TTM through Dec 2018 was $1.6 million, a 77.69% decrease, with the full-year FY2018 number at $1.6 million, down 77.69% from a year prior.
  • Change in Inventory was $1.1 million for Q4 2018 at Theravance Biopharma, up from $201000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $4.3 million in Q4 2017 to a low of -$912000.0 in Q4 2015.
  • A 5-year average of $885500.0 and a median of $306000.0 in 2015 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: skyrocketed 7096.15% in 2014, then crashed 542.72% in 2015.
  • Theravance Biopharma's Change in Inventory stood at $206000.0 in 2014, then plummeted by 542.72% to -$912000.0 in 2015, then surged by 247.37% to $1.3 million in 2016, then skyrocketed by 222.77% to $4.3 million in 2017, then tumbled by 75.17% to $1.1 million in 2018.
  • Per Business Quant, the three most recent readings for TBPH's Change in Inventory are $1.1 million (Q4 2018), $201000.0 (Q3 2018), and -$20000.0 (Q2 2018).